Onabotulinumtoxin type A improves lower urinary tract symptoms and quality of life in patients with human T cell lymphotropic virus type 1 associated overactive bladder

AIM: To evaluate the efficacy of the onabotulinum toxin type A in the treatment of HTLV-1 associated overactive bladder and its impact on quality of life (QoL). METHODS: Case series with 10 patients with overactive bladder refractory to conservative treatment with anticholinergic or physical therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Carneiro Neto, Jose Abraão, Santos, Silvane Braga, Orge, Gloria Orge, Tanajura, Davi, Passos, Lucia, Oliveira, Cassius José, Andrade, Rosana, Melo, Cláudio Galeno de, Barroso, Ubirajara, Carvalho, Edgar M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428232/
https://www.ncbi.nlm.nih.gov/pubmed/29462596
http://dx.doi.org/10.1016/j.bjid.2017.10.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428232/
https://www.ncbi.nlm.nih.gov/pubmed/29462596
http://dx.doi.org/10.1016/j.bjid.2017.10.009

Ejemplares similares